News

McEwen Mining Reports Impressive Q3 2024 Financial Growth

McEwen Mining Reports Impressive Q3 2024 Financial Growth

McEwen Mining's Solid Performance in Q3 2024

McEwen Mining Inc. (NYSE: MUX) has unveiled impressive financial and operational results for the third quarter of 2024. The substantial revenue and operating profit gains were mainly driven by increased gold prices coupled with robust production levels. This performance underscores the company's commitment to expanding its gold and silver production, advancing a major copper project, and investing significantly in exploration activities.

Financial Highlights

In comparison with the same quarter last year, McEwen Mining's Q3 2024 results revealed remarkable growth:

  • Revenue rose by 36% to $52.3 million. This increase was supported by higher gold prices, averaging $2,499 per ounce compared to $1,920 in Q3 2023, alongside a boost in the production of gold equivalent ounces (GEOs) from the company's 100%-owned mines.
  • Gross profit surged 268% to $13.8 million. Enhanced operational efficiencies and increased production levels contributed to this notable gain.
  • The net loss in Q3 significantly decreased to $2.1 million or $0.04 per share, a considerable reduction from the previous year's loss of $18.5 million or $(0.39) per share, demonstrating effective cost control measures.
  • Operating cash flow improved to $23.2 million or $0.45 per share, reversing last year's negative cash flow of $2.3 million or $(0.04) per share.
  • Adjusted EBITDA skyrocketed 586% to $10.5 million or $0.20 per share, enhancing operational earnings and cash flow visibility.

Operational Achievements

Key operational highlights from the quarter include:

  • Gold Bar Mine in Nevada. The mine produced 13,640 ounces of gold, a remarkable 43% increase from 2023, aided by better recovery metrics and higher gold grades.
  • Fox Complex in Canada. Gold production reached 7,855 ounces, marking a 30% decline due to temporary setbacks stemming from a stope failure earlier in the year, but the outlook for Q4 is positive.
  • San José Mine in Argentina. The mine produced 13,684 GEOs, reflecting a 23% drop due to lower grades, though annual guidance remains achievable.

Highlights on Safety and Corporate Developments

McEwen Mining has also prioritized safety, achieving impressive records at various sites — Gold Bar Mine reported 54 months without lost time injuries, while the Fox Complex has achieved 33 months. 

Corporate advancements included a successful $56 million capital raise for its McEwen Copper division, which will bolster the development of the Los Azules copper project. This investment also elevated McEwen Mining’s ownership in McEwen Copper to 46.4%.

Exploration and Future Growth Initiatives

Investment in exploration remained strong, with $6.1 million dedicated to the Los Azules project and $5.3 million across its Nevada sites. The continuity of these investments positions McEwen Mining for long-term growth:

  • Los Azules Copper Project: Progress is on track for a feasibility study set for release in the first half of 2025, with funding expected to support broad exploration initiatives.
  • Gold Bar Mine: Current exploration efforts are focusing on drilling near existing infrastructure, aiming to extend the mine's operational life and develop new resource areas.
  • Fox Complex: Actions taken during the first nine months of the year included earthwork preparations for ramp connections, as well as plans to rehabilitate the historic Stock shaft for enhanced access and production capabilities.

Management Engagement Strategies

Looking ahead, McEwen Mining's management plans to engage with stakeholders through a management conference call aimed at discussing Q3 financial results and core growth initiatives. Participants will also have the opportunity to take part in a Q&A session following the presentation.

Frequently Asked Questions

1. What were the key financial achievements of McEwen Mining in Q3 2024?

McEwen Mining reported a 36% increase in revenue to $52.3 million and a gross profit rise of 268% to $13.8 million, alongside a significantly reduced net loss.

2. How did gold production perform across McEwen Mining's mines?

The Gold Bar Mine produced 13,640 ounces, a 43% increase, while the Fox Complex experienced a decrease to 7,855 ounces due to operational challenges.

3. What are McEwen Mining's future exploration plans?

The company invested heavily in projects like Los Azules, aiming for a feasibility study in 2025 while also continuing exploration initiatives at Gold Bar and the Fox Complex.

4. What safety measures are in place at McEwen Mining's sites?

McEwen Mining emphasizes safety, reporting 54 months with no lost time injuries at Gold Bar Mine, maintaining a strong safety commitment across operations.

5. How is McEwen Mining positioning itself for future profitability?

By focusing on operational efficiencies, cost management, and funding growth initiatives, McEwen Mining aims to enhance productivity and increase shareholder value.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lilly's Digital Healthcare Push with Hims & Hers

Updated Category News Views 194

Revolutionizing Access: Pharmaceuticals Meet Telehealth In an era where digital disruption is shaking every sector, Eli Lilly (NYSE:LLY) isn't sitting idle. They've just forged a partnership with Hims & Hers (NYSE:HIMS), one that's diving headfirst into the telehealth revolution. We're talking a slick merger of pharmaceuticals and digital platforms—offering FDA-approved...

Continue Reading
Delta Dental Expands Free Oral Care Access in NM

Updated Category News Views 160

Bridging Dental Care Gaps in New Mexico When the calendar flips to early November, Delta Dental of New Mexico is joining hands with the NM Mission of Mercy for a no-cost dental clinic at EXPO New Mexico. We're talking doors flying open at 5:15 a.m. sharp, on November 6 and 7. This isn’t some run-of-the-mill thing—they are targeting those who can't easily get or afford...

Continue Reading
Sass Magazine's 2026 COZY Issue Embraces Intentional Joy

Updated Category News Views 102

An Unexpected Shift in Sass's Seasonal Focus When you think November and December, it's easy to picture the hustle and bustle of holiday preparations—shopping, parties, running around. But toss all that hullabaloo out the window, because Sass Magazine has thrown a curveball for their 2026 release. They're steering the ship towards the calm, with their COZY Issue shaping...

Continue Reading
Lululemon Faces Class Action Amid Sales Decline

Updated Category News Views 136

Looks like Lululemon Athletica Inc. (NASDAQ: LULU) is in the hot seat, and not in the cozy yoga session kind of way. Investors are gearing up for a legal face-off thanks to a class action lawsuit alleging some serious corporate sleight of hand. What Triggered This Legal Storm? Turns out, between March 18 and September 3, 2026, things didn't go as planned for Lululemon....

Continue Reading
Tenax Sued: Investors Face Class Action Over TNX-103

Updated Category News Views 83

What Tenax Investors Need to Know Alright, folks, time to pull up a chair and pay attention to what's brewing with Tenax Therapeutics—yeah, we're talking NASDAQ: TENX. The company's head is spinning as it's caught up in a securities class action lawsuit. What's the fuss? The fine print here accuses Tenax of misleading investors about the effectiveness of their product,...

Continue Reading
TCL CSOT's OLED Move In Marks Next Phase of Growth

Updated Category News Views 96

A Landmark Moment in OLED Manufacturing Alright, let me drop a quick line here. TCL CSOT just shifted gears with their t8 production line in Guangzhou. It’s not your typical assembly line story—this one's all about pulling the future into the present. We're talking the world's first 8.6-generation Inkjet Printing OLED production line, for crying out loud. They've just...

Continue Reading
Datavault AI's Turbulent Boardroom Saga Escalates

Updated Category News Views 104

The Corporate Chess Game at Datavault AI If there's one thing Wall Street hates, it's uncertainty. And boy, does Datavault AI (NASDAQ: DVLT) deliver plenty of it right now. Founder Nathaniel Bradley has lobbed a lawsuit at the board, claiming that Chairman and CFO Brett Moyer orchestrated a coup to oust him without proper board procedures. Talk about drama fit for a soap...

Continue Reading
Koppers Navigates Q3: Margins Squeeze Amid Growth

Updated Category News Views 117

Investing in Koppers: A Mixed Bag in Q3 Well, it appears Koppers (NYSE: KOP) is doing a bit of a dance this quarter—some smooth steps, but a few stumbles in the rhythm when it comes to margins. The hardwood numbers tell an interesting tale, so let's break it down. Sales Edge Up, But Margins Suffer Koppers clocked in net sales of $499.1 million for the third quarter of...

Continue Reading
New Frontiers in Glaucoma Care: Less Drops Required?

Updated Category News Views 77

Eyeing New Glaucoma Treatment Strategies You think glaucoma treatment is all about popping eye drops day in and day out? Well, turns out, things are shifting down in Racine, Wisconsin. Folks at HelloNation have been spilling the beans on earlier glaucoma interventions that might just lighten your load of daily medications. Doctors I. Paul Singh and R. Krishna Sanka...

Continue Reading
MNTN Revenue Miss Sparks Shareholder Investigation

Updated Category News Views 79

When Revenue Goes South, Shares Follow Nothing like a Friday morning stock bloodbath to shake things up. MNTN, Inc. (NYSE:MNTN) had traders tossing back extra caffeine shots on November 5, 2026, when the company reported third-quarter revenues of $80.3 million. Let's just say that number didn't quite sit well with the folks who'd been banking on an $87.7 million...

Continue Reading

Top 5 Most Recently Viewed Articles

Perpetua Resources Corp. Class Action Lawsuit and Investor Alert

Updated Category News Views 167

Understanding the Class Action Lawsuit Against Perpetua Resources Corp. Investors in Perpetua Resources Corp. (NASDAQ: PPTA) should take note of recent developments regarding a class action securities lawsuit aimed at recovering losses incurred due to alleged securities fraud. This legal action encompasses claims made during a specific period, potentially affecting a...

Continue Reading
Telix Pharmaceuticals Hits Record Revenue and Expands Guidance

Updated Category News Views 390

Telix Pharmaceuticals Reports Record Revenues in Q3 2025 Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) has unveiled an impressive financial performance for the third quarter of 2025, showcasing unaudited group revenues of approximately $206 million. This figure marks a substantial year-over-year increase of 53%, revealing the company's significant growth...

Continue Reading
Bio-Techne Showcases Breakthrough Solutions at Neuroscience 2024

Updated Category News Views 208

Bio-Techne's Commitment to Neuroscience Research Bio-Techne Corporation (NASDAQ: TECH) is preparing for an exciting presentation at the Society for Neuroscience's annual meeting, Neuroscience 2024. Scheduled for October 5-9 in Chicago, this prestigious event will feature Bio-Techne as they share advancements that are setting new standards in neuroscience research....

Continue Reading
Important Update for Lineage, Inc. Investors on Class Action

Updated Category News Views 214

Class Action Suit Opportunities for Lineage, Inc. Investors The Rosen Law Firm, known for advocating investor rights, is calling attention to an essential opportunity for those who purchased common stock of Lineage, Inc. (NASDAQ: LINE). Investors should be aware of the impending lead plaintiff deadline of September 30, 2025. Why Join the Lawsuit? If you bought shares of...

Continue Reading
AST SpaceMobile Prepares for BlueBird 6 Launch and Future Growth

Updated Category News Views 129

AST SpaceMobile Gears Up for BlueBird 6 Launch AST SpaceMobile is set to launch its advanced satellite, BlueBird 6, marking a significant milestone for the company. This launch is crucial for boosting the firm’s space-based cellular broadband network and is being closely watched by investors eager to understand the company’s expansion into full-scale operations. Key...

Continue Reading